Allergan's Restasis Multidose 0.05% Approved in Canada

Allergan's Restasis Multidose 0.05% Approved in Canada

Allergan has received approval from Health Canada for Restasis Multidose (Cyclosporine Ophthalmic Emulsion) 0.05%.

Restasis Multidose is a preservative-free, multi-dose bottle offering the same preservative-free formulation of Restasis, in a new, easy-to-use multi-dose bottle.

Restasis starts to reverse the cycle of inflammation when treatment begins, and works to improve ocular surface health and tear quality as treatment continues. Restasis alleviates the feelings of dryness, grittiness, burning and stinging and it helps improve the ability to perform daily activities like driving, reading or using a computer.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!

"Restasis Multidose will be an important addition to the treatment options available to patients, as it will enable healthcare providers to offer an additional option for those patients who may prefer their eye drops in a multi-dose bottle versus single-use vials," said Dry Eye expert Dr. Bruce Jackson, MD, RCPSC.

Restasis Multidose, the only multi-dose Preservative Free prescription option for the treatment of Dry Eye, is designed with a patented unidirectional valve and air filter technology that eliminates the need for a preservative. The new multi-dose bottle uses less plastic than a package of single-use vials, and provides a convenient solution for patients who prefer multi-dose formats.

The new Restasis Multidose bottle is an advanced delivery system which ensures sterility to prevent contamination. The bottle is slightly larger and easier to manipulate than the single-use vials for many patients.

"Restasis Multidose exemplifies Allergan's commitment to innovation and customer responsiveness," said Carmen Enciu, Medical Director and Head of the Canadian Chief Medical Office, Allergan Canada. "Through our Open Science model, we strive to deliver advancements to help improve patient care, such as the new multi-dose bottle."

Restasis Multidose will be available in Canada this summer with specific timing to be confirmed.

  • <<
  • >>

Join the Discussion